Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis B and Hepatitis C”

192 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 192 results

Testing effectiveness (Phase 2)Study completedNCT00956098
What this trial is testing

Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis

Who this might be right for
Liver FibrosisLiver Cirrhosis
HK inno.N Corporation 81
Not applicableUnknownNCT01927133
What this trial is testing

LIVER FIBROSIS PREVALENCE IN FRANCE

Who this might be right for
Liver Fibrosis Progression in Chronic Liver Disease
Assistance Publique - Hôpitaux de Paris 10,000
Large-scale testing (Phase 3)Study completedNCT02613871
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Not applicableStudy completedNCT02402699
What this trial is testing

Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan

Who this might be right for
Advanced MelanomaHepatitis BHepatitis C
Bristol-Myers Squibb 3
Not applicableStudy completedNCT07236268
What this trial is testing

Prevalence of HIV and Sexually Transmitted Infections in Migrant Communities in Slovakia

Who this might be right for
STIsHIVRapid Detection
Comenius University 660
Early research (Phase 1)Study completedNCT02259855
What this trial is testing

Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment

Who this might be right for
Hepatic Insufficiency
Boehringer Ingelheim 36
Not applicableLooking for participantsNCT00001971
What this trial is testing

Evaluation of Patients With Liver Disease

Who this might be right for
Hepatitis DHepatitis CHepatitis B+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8,050
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Not applicableStudy completedNCT01859884
What this trial is testing

Optimizing Kidney Transplant Informed Consent

Who this might be right for
End-stage Kidney Disease
Northwestern University 288
Not applicableNot Yet RecruitingNCT07241962
What this trial is testing

Hepatitis B and C Within the Chinese Community in Milan

Who this might be right for
HBV (Hepatitis B Virus)HCV Infection
IRCCS Ospedale San Raffaele 1,000
Large-scale testing (Phase 3)Study completedNCT02483156
What this trial is testing

Randomized, Open-Label, Study to Evaluate the Safety and Efficacy of Sofosbuvir Tablet Plus Ribavirin Tablet (Part A) Versus Single Dose (2 Tablets) of EHCV Containing Sofosbuvir, Ribavirin, and Natural Anti-hemolytic (B) in Egyptian Adults With Chronic Genotype 4 HCV Infection

Who this might be right for
Hepatitis c
Egyptian Liver Hospital 80
Large-scale testing (Phase 3)Study completedNCT00317109
What this trial is testing

Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 168
Large-scale testing (Phase 3)UnknownNCT00154869
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C

Who this might be right for
Hepatitis B, ChronicHepatitis C, Chronic
National Taiwan University Hospital 320
Not applicableLooking for participantsNCT05361603
What this trial is testing

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Who this might be right for
Hepatitis CTransmission, Intravenous Drug AbuserAddiction, Alcohol+2 more
University Hospital, Limoges 1,500
Not applicableStudy completedNCT00361179
What this trial is testing

Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C

Who this might be right for
Coinfection With Hepatitis B Virus and Hepatitis C VirusMonoinfection With Hepatitis C Virus
National Taiwan University Hospital 320
Not applicableWithdrawnNCT02658786
What this trial is testing

Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver Disease

Who this might be right for
HBVNAFLDHCV
Institute of Liver and Biliary Sciences, India
Large-scale testing (Phase 3)Ended earlyNCT00678587
What this trial is testing

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Who this might be right for
Non-alcoholic SteatohepatitisChronic Liver DiseaseHCV+8 more
GlaxoSmithKline 292
Not applicableNot Yet RecruitingNCT06244966
What this trial is testing

GUM Remote Testing v4.0

Who this might be right for
HIV InfectionsSyphilis InfectionHepatitis B and Hepatitis C
Royal Devon and Exeter NHS Foundation Trust 40
Not applicableNot Yet RecruitingNCT07298577
What this trial is testing

Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

Who this might be right for
Liver CirrhosisHepatitis B, ChronicHepatitis C, Chronic+1 more
Siriraj Hospital 2,100
Not applicableEnded earlyNCT00767936
What this trial is testing

Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

Who this might be right for
Liver CancerHepatitis BHepatitis C+2 more
Stanford University 135
Load More Results